New joint publication with International Flavors & Fragrances Inc (IFF) and Research Institute for Fragrance Materials (RIFM). SenzaGen scientists, alongside the scientific teams at International Flavors & Fragrances Inc and […]
Peer-reviewed article in Frontiers in Toxicology. The application of GARD®skin to predict potential skin sensitizers in extracts from Medical Device materials has recently been published in a peer-reviewed article in […]
New joint publication with Corteva Agriscience. SenzaGen scientists, alongside the toxicology team at Corteva Agriscience, have recently published a joint study in Regulatory Toxicology and Pharmacology, presenting new peer-reviewed evidence […]
Click image to view the newsletter in browser.
Practical application of the GARD®skin Dose-Response assay to derive a No Expected Sensitization Induction Level (NESIL) value for confirmatory human patch studies to determine safe use level for novel fragrance […]
New scientific publication by ExxonMobil. Check out this newly published article by ExxonMobil focusing on the challenges of determining skin sensitization hazard in the case of difficult-to-test substances with conflicting […]
Regulatory approval of medical devices according to MDR using in vitro data from GARDskin Medical Device for skin sensitization assessment Presented at Eurotox 2023 Download a copy Conclusion The […]
Assessing the Utility of the Genomic Allergen Rapid Detection (GARDskin) Assay to Detect Dermal Sensitization Potential in UVCBs and Formulated Lubricant Products Presented at Eurotox 2023 Download a copy […]
The GARDskin Dose-Response assay for determination of a point-of-departure (PoD) for Next Generation Risk Assessment (NGRA) of skin sensitizers: A case study using isocyclocitral Presented at Eurotox 2023 Download a […]
Expanding the applicability domain of NAMs for skin sensitization testing: A case study using GARDskin for assessment of metals Presented at the 12th World Congress on Alternatives and Animal Use […]
